Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Grows By 26.9%

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 77,000 shares, an increase of 26.9% from the February 13th total of 60,700 shares. Based on an average daily volume of 268,300 shares, the days-to-cover ratio is presently 0.3 days.

Coloplast A/S Stock Performance

OTCMKTS:CLPBY opened at $10.62 on Tuesday. The stock has a 50-day moving average price of $11.06 and a 200 day moving average price of $12.08. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92. Coloplast A/S has a 12-month low of $10.43 and a 12-month high of $14.14.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a net margin of 17.81% and a return on equity of 28.60%. On average, sell-side analysts expect that Coloplast A/S will post 0.31 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CLPBY shares. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th. Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research report on Monday, November 18th. Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, Royal Bank of Canada raised Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 3rd.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.